Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Recent studies have demonstrated a strong association between SWAP70 (HGNC:17070) and rheumatoid arthritis (MONDO_0008383). Two independent multi‐patient studies have reported significant association signals in distinct populations. In a Chinese cohort of 600 patients and 800 controls, an association was established with a risk variant (rs360136) and differential gene expression, while a large Korean GWAS study including 4,068 cases and 36,487 controls further supported SWAP70 as a susceptibility locus (PMID:35016729, PMID:32723749). These robust population studies offer strong statistical evidence for SWAP70’s role in disease risk.
The genetic evidence is reinforced by functional assessments. In vitro studies have explored the role of the SWAP70 PH domain in membrane targeting and cellular signaling. One study demonstrated that point mutations within the PH domain abolished phosphatidylinositol trisphosphate binding and impeded proper membrane translocation, a function critical for membrane ruffling, an event linked to immune cell activation (PMID:16786189). Further functional assessments confirmed that specific mutations impair additional activities of the PH domain, contributing to altered cellular behavior (PMID:17454301). Moreover, a mutant version of SWAP70 (SWAP-70-374) was shown to trigger transformation in mouse embryo fibroblasts and activate the ERK1/2 pathway, further correlating SWAP70 dysfunction with pathogenic cellular outcomes (PMID:21152038).
While segregation analysis in families is not available for this complex trait, the converging evidence from both large-scale genetic studies and multiple functional assays confirms SWAP70’s contribution to rheumatoid arthritis. The genetic data meets ClinGen criteria based on replication in ethnically diverse cohorts with strong statistical support, and the functional data indicate a plausible mechanism through aberrant signaling and membrane dynamics.
Integrating these findings, SWAP70 emerges as a strong candidate gene in rheumatoid arthritis pathogenesis. The multi-population genetic associations paired with mechanistic insights offer clinicians and researchers compelling, actionable evidence that may inform diagnostic strategies and therapeutic development.
Key Take‑home: SWAP70’s validated genetic association and mechanistic impact on immune cell function underscore its clinical utility as a diagnostic and potentially therapeutic marker in rheumatoid arthritis.
Gene–Disease AssociationStrongAssociation supported by two independent multi‑patient studies in Chinese (600 patients, 800 controls [PMID:35016729]) and Korean (4,068 cases, 36,487 controls [PMID:32723749]) cohorts demonstrating significant risk associations. Genetic EvidenceStrongRobust GWAS data from diverse ethnic cohorts establish a consistent association between SWAP70 and rheumatoid arthritis, fulfilling ClinGen criteria for genetic evidence. Functional EvidenceModerateIn vitro functional assays indicate that mutations affecting the SWAP70 PH domain disrupt membrane targeting and signaling, providing mechanistic support with multiple studies ([PMID:16786189], [PMID:17454301], [PMID:21152038]). |